Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
HCA Stock Forecast 2026-2027
$488.00
Current Price
$109.13B
Market Cap
Buy 15
Hold 9
Sell 1
Wall St Analyst Ratings
Distance to HCA Price Targets
+30.1%
To High Target of $635.00
+12.9%
To Median Target of $551.00
-12.9%
To Low Target of $425.00
HCA Price Momentum
-1.9%
1 Week Change
-1.2%
1 Month Change
+45.7%
1 Year Change
+4.5%
Year-to-Date Change
-12.3%
From 52W High of $556.52
+55.2%
From 52W Low of $314.43
📊 TOP ANALYST CALLS
Did HCA Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if HCA Healthcare is one of their latest high-conviction picks.
Latest HCA Stock Price Targets & Analyst Predictions
Based on our analysis of 45 Wall Street analysts, HCA has a bullish consensus with a median price target of $551.00 (ranging from $425.00 to $635.00). The overall analyst rating is Strong Buy (8.1/10). Currently trading at $488.00, the median forecast implies a 12.9% upside. This outlook is supported by 15 Buy, 9 Hold, and 1 Sell ratings.
The most optimistic forecast comes from Andrew Mok at UBS, projecting a 30.1% upside. Conversely, the most conservative target is provided by Craig Hettenbach at Morgan Stanley, suggesting a 12.9% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
HCA Analyst Ratings
15
Buy
9
Hold
1
Sell
HCA Price Target Range
Low
$425.00
Average
$551.00
High
$635.00
Current: $488.00
Latest HCA Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for HCA.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 10, 2026 | TD Cowen | Ryan Langston | Buy | Maintains | $561.00 |
| Feb 25, 2026 | Mizuho | Ann Hynes | Outperform | Maintains | $585.00 |
| Feb 23, 2026 | UBS | Andrew Mok | Buy | Maintains | $635.00 |
| Feb 20, 2026 | JP Morgan | Benjamin Rossi | Neutral | Maintains | $535.00 |
| Feb 6, 2026 | Argus Research | David Toung | Buy | Maintains | $560.00 |
| Jan 30, 2026 | Wells Fargo | Stephen Baxter | Equal-Weight | Maintains | $481.00 |
| Jan 28, 2026 | Cantor Fitzgerald | Sarah James | Overweight | Maintains | $588.00 |
| Jan 28, 2026 | Barclays | Andrew Mok | Overweight | Maintains | $551.00 |
| Jan 28, 2026 | Truist Securities | David Macdonald | Buy | Maintains | $546.00 |
| Jan 28, 2026 | Jefferies | Brian Tanquilut | Buy | Maintains | $590.00 |
| Jan 28, 2026 | Deutsche Bank | Pito Chickering | Buy | Maintains | $558.00 |
| Jan 28, 2026 | RBC Capital | Ben Hendrix | Outperform | Maintains | $555.00 |
| Jan 28, 2026 | Keybanc | Matthew Gillmor | Overweight | Maintains | $550.00 |
| Jan 28, 2026 | Oppenheimer | Michael Wiederhorn | Outperform | Maintains | $540.00 |
| Jan 28, 2026 | UBS | Andrew Mok | Buy | Maintains | $598.00 |
| Jan 7, 2026 | Wells Fargo | Stephen Baxter | Equal-Weight | Maintains | $452.00 |
| Dec 18, 2025 | Mizuho | Ann Hynes | Outperform | Maintains | $520.00 |
| Dec 15, 2025 | Morgan Stanley | Craig Hettenbach | Underweight | Downgrade | $425.00 |
| Nov 13, 2025 | Wells Fargo | Stephen Baxter | Equal-Weight | Maintains | $431.00 |
| Oct 28, 2025 | Jefferies | Brian Tanquilut | Buy | Maintains | $525.00 |
HCA Healthcare Inc. (HCA) Competitors
The following stocks are similar to HCA Healthcare based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
HCA
HCA Healthcare
mkt cap
109.13B
HCA Healthcare Inc. (HCA) Financial Data
HCA Healthcare Inc. has a market capitalization of $109.13B with a P/E ratio of 17.2x. The company generates $75.60B in trailing twelve-month revenue with a 9.0% profit margin.
Revenue growth is +6.7% quarter-over-quarter, while maintaining an operating margin of +16.3% and return on equity of -244.8%.
Valuation Metrics
Market Cap
$109.13B
Enterprise Value
$159.94B
P/E Ratio
17.2x
PEG Ratio
0.4x
Price/Sales
1.4x
Growth & Margins
Revenue Growth (YoY)
+6.7%
Gross Margin
+41.9%
Operating Margin
+16.3%
Net Margin
+9.0%
EPS Growth
+30.6%
Financial Health
Cash/Price Ratio
+1.0%
Current Ratio
1.0x
Debt/Equity
-17.6x
ROE
-244.8%
ROA
+12.4%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
HCA Healthcare Inc. (HCA) Business Model
About HCA Healthcare Inc.
What They Do
Provides comprehensive healthcare services and facilities.
Business Model
The company operates hospitals and extensive outpatient care networks, generating revenue through patient admissions, surgeries, and ancillary services. It leverages economies of scale and shared resources to enhance efficiency and reduce costs, ensuring high-quality care tailored to community needs.
Additional Information
HCA Healthcare was founded in 1968 and is headquartered in Nashville, Tennessee. It operates approximately 186 hospitals and around 2,400 care sites across 20 states and the UK, with a significant presence in high-demand regions like Florida and Texas.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
230,000
CEO
Mr. Samuel N. Hazen
Country
United States
IPO Year
2011
Website
www.hcahealthcare.comHCA Healthcare Inc. (HCA) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Here's Why HCA Healthcare (HCA) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Apr 13, 2026
By Zacks Equity Research
Tale of the Tape
Here's Why HCA Healthcare (HCA) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Apr 08, 2026
By Zacks Equity Research
Tale of the Tape
Latest News
29 HCA Healthcare Hospitals Recognized on Modern Healthcare's 100 Top Hospitals Powered by Premier
3 days ago
Quick Summary
HCA Healthcare, Inc. announced that 29 of its hospitals were recognized as top performers in the 2026 Modern Healthcare 100 Top Hospitals, highlighting the quality of care provided.
Why It Matters
HCA Healthcare's recognition of 29 hospitals as top performers may boost its reputation, attract more patients, and potentially increase revenue, impacting stock performance positively.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Zacks Style Scores help investors identify top-rated stocks tailored to their investment strategies, providing a beneficial tool for stock selection.
Why It Matters
The Zacks Style Scores can help investors identify high-potential stocks tailored to their strategies, enhancing decision-making and potentially improving returns.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
The March jobs report revealed the creation of 178,000 jobs, with 76,000 in the healthcare sector, indicating positive employment growth.
Why It Matters
The addition of 178,000 jobs, particularly 76,000 in healthcare, signals economic growth and sector strength, influencing market sentiment and potential stock performance.
Source: MarketBeat
Market Sentiment:
Positive
Quick Summary
Zacks Style Scores can help investors identify strong, market-beating stocks for their portfolios.
Why It Matters
Zacks Style Scores provide a systematic way to identify potentially outperforming stocks, guiding investors toward stronger portfolio selections and improved returns.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
March jobs data shows gains in Healthcare, Transport, and Construction sectors, with ETFs in these areas benefiting from increased hiring and steady demand.
Why It Matters
Sector-specific ETFs in healthcare, transport, and construction show growth potential, indicating strong job market recovery and consumer demand, which can boost stock performance in these areas.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
HCA Healthcare will donate $2 million to Second Harvest Food Bank for its new Grow for Good campus in Nashville, addressing a 46% increase in demand for assistance since 2020.
Why It Matters
HCA Healthcare's $2 million donation enhances its community engagement, potentially improving its public image and aligning with social responsibility trends, which can positively impact investor sentiment.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About HCA Stock
What is HCA Healthcare Inc.'s (HCA) stock forecast for 2026?
Based on our analysis of 45 Wall Street analysts, HCA Healthcare Inc. (HCA) has a median price target of $551.00. The highest price target is $635.00 and the lowest is $425.00.
Is HCA stock a good investment in 2026?
According to current analyst ratings, HCA has 15 Buy ratings, 9 Hold ratings, and 1 Sell ratings. The stock is currently trading at $488.00. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for HCA stock?
Wall Street analysts predict HCA stock could reach $551.00 in the next 12 months. This represents a 12.9% increase from the current price of $488.00. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is HCA Healthcare Inc.'s business model?
The company operates hospitals and extensive outpatient care networks, generating revenue through patient admissions, surgeries, and ancillary services. It leverages economies of scale and shared resources to enhance efficiency and reduce costs, ensuring high-quality care tailored to community needs.
What is the highest forecasted price for HCA HCA Healthcare Inc.?
The highest price target for HCA is $635.00 from Andrew Mok at UBS, which represents a 30.1% increase from the current price of $488.00.
What is the lowest forecasted price for HCA HCA Healthcare Inc.?
The lowest price target for HCA is $425.00 from Craig Hettenbach at Morgan Stanley, which represents a -12.9% decrease from the current price of $488.00.
What is the overall HCA consensus from analysts for HCA Healthcare Inc.?
The overall analyst consensus for HCA is bullish. Out of 45 Wall Street analysts, 15 rate it as Buy, 9 as Hold, and 1 as Sell, with a median price target of $551.00.
How accurate are HCA stock price projections?
Stock price projections, including those for HCA Healthcare Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 19, 2026 5:00 PM UTC